Globus Medical (MEX:GMED) OCF Margin %: 26.63% (As of Mar. 2026) — Near Median


MEX:GMED Globus Medical Inc MEX:GMED
92 GF Score
Price MXN1,355.65
GF Value MXN1,670.17
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Globus Medical OCF Margin %?

Globus Medical MEX:GMED 92 OCF Margin % is 26.63% as of Mar. 2026, which is 6% above its 10-year median of 25.10. GuruFocus rates MEX:GMED with a GF Score™ of 92/100 and a GF Value™ of MXN1,670.17 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Globus Medical ranks better than 88.34% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Globus Medical's Cash Flow from Operations for the three months ended in Mar. 2026 was MXN3,649 Mil. Globus Medical's Revenue for the three months ended in Mar. 2026 was MXN13,702 Mil. Therefore, Globus Medical's OCF Margin % for the quarter that ended in Mar. 2026 was 26.63%.

As of today, Globus Medical's current OCF Yield % is 7.17%.

The historical rank and industry rank for Globus Medical's OCF Margin % or its related term are showing as below:

MEX:GMED' s OCF Margin % Range Over the Past 10 Years
Min: 15.52   Med: 25.1   Max: 28.84
Current: 24.96


During the past 13 years, the highest OCF Margin % of Globus Medical was 28.84%. The lowest was 15.52%. And the median was 25.10%.

MEX:GMED's OCF Margin % is ranked better than
88.34% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.86 vs MEX:GMED: 24.96


Globus Medical OCF Margin % Related Terms


Globus Medical OCF Margin % Historical Data

* Premium members only.

The historical data trend for Globus Medical's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Globus Medical OCF Margin % Chart

Globus Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.84 17.45 15.52 20.67 25.64

Globus Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.64 10.45 32.47 30.08 26.63

MEX:GMED vs PODD, PEN, MASI: OCF Margin % Comparison

For the Medical Devices subindustry, Globus Medical's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Globus Medical OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Globus Medical's OCF Margin % falls into.


MEX:GMED
92GF Score
Globus Medical Inc MEX:GMED
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Globus Medical OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Globus Medical's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=13566.341/52917.51
=25.64 %

Globus Medical's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=3649.169/13702.219
=26.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 26.63% mean?
Globus Medical (MEX:GMED) has a OCF Margin % of 26.63% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Globus Medical and its competitors. This is near median its historical median of 25.10. Over the past decade, Globus Medical's OCF Margin % has ranged from 15.52 to 28.84. According to the industry distribution chart, Globus Medical ranks #95 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 11.7%.
Is Globus Medical's OCF Margin % too high?
Globus Medical's current OCF Margin % of 26.63% is near median its 10-year median of 25.10. Over the past 10 years, this metric has ranged from a low of 15.52 to a high of 28.84. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Globus Medical's value of 26.63% is 354.4% above this industry median. Based on the distribution chart, Globus Medical ranks #95 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Globus Medical has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's OCF Margin % compare to PODD and PEN?
According to the Medical Devices & Instruments industry distribution chart, Globus Medical ranks #95 out of 815 companies for OCF Margin %. This places Globus Medical in the top 12% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. Globus Medical's value of 26.63% is 354.4% above this benchmark. Historically, Globus Medical's own OCF Margin % has ranged from 15.52 to 28.84 over the past decade. While the company's 10-year median is 25.10 vs. the industry median of 5.86, Globus Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Globus Medical's current OCF Margin % of 26.63% is 354.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Globus Medical and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Globus Medical's current OCF Margin % is 26.63%, which is near median its own 10-year median of 25.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (MEX:GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,670.17, compared to a current price of MXN1,355.65 — trading 18.8% below its estimated fair value. The current OCF Margin % is 26.63%, which is near median its 10-year median of 25.10 and 354.4% above the Medical Devices & Instruments industry median of 5.86. Globus Medical's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Globus Medical (MEX:GMED), the current OCF Margin % is 26.63% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Globus Medical (MEX:GMED) Overvalued in 2026?

Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued. The current stock price of MXN1,355.65 is trading 18.8% below its estimated GF Value™ of MXN1,670.17. GuruFocus considers Globus Medical to be Modestly Undervalued.

Key valuation signals for MEX:GMED:

  • OCF Margin %: 26.63% (near median its 10-year median of 25.10)
  • GF Value™: MXN1,670.17 vs. price of MXN1,355.65 (18.8% below fair value)
  • GF Score™: 92/100 with 4 warning signs
  • Industry Position: 354.4% above the Medical Devices & Instruments median (#95 of 815)

No single metric tells the full story. See the MEX:GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Globus Medical Business Description

Other Exchanges GMED:USAGM0N:Germany
Address 2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
92GF Score

Get the complete analysis for MEX:GMED

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,355.65
Price
MXN1,670.17
GF Value